SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-20-003043
Filing Date
2020-01-10
Accepted
2020-01-10 16:11:32
Documents
92
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm1927377-1_10k.htm 10-K 1420492
2 EXHIBIT 4.5 tm1927377d1_ex4-5.htm EX-4.5 47442
3 EXHIBIT 10.29 tm1927377d1_ex10-29.htm EX-10.29 20895
4 EXHIBIT 10.30 tm1927377d1_ex10-30.htm EX-10.30 8613
5 EXHIBIT 10.31 tm1927377d1_ex10-31.htm EX-10.31 10022
6 EXHIBIT 21.1 tm1927377d1_ex21-1.htm EX-21.1 2048
7 EXHIBIT 23.1 tm1927377d1_ex23-1.htm EX-23.1 2730
8 EXHIBIT 23.2 tm1927377d1_ex23-2.htm EX-23.2 2951
9 EXHIBIT 31.1 tm1927377d1_ex31-1.htm EX-31.1 10657
10 EXHIBIT 31.2 tm1927377d1_ex31-2.htm EX-31.2 10612
11 EXHIBIT 32.1 tm1927377d1_ex32-1.htm EX-32.1 6982
12 GRAPHIC tm1927377-1_10kimg001.jpg GRAPHIC 102817
13 GRAPHIC tm1927377d1_ex10-29img001.jpg GRAPHIC 112083
14 GRAPHIC tm1927377d1_ex10-30img001.jpg GRAPHIC 113900
15 GRAPHIC tm1927377d1_ex10-31img001.jpg GRAPHIC 175541
  Complete submission text file 0001104659-20-003043.txt   7146523

Data Files

Seq Description Document Type Size
16 XBRL INSTANCE DOCUMENT nbse-20190930.xml EX-101.INS 1249942
17 XBRL TAXONOMY EXTENSION SCHEMA nbse-20190930.xsd EX-101.SCH 57949
18 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbse-20190930_cal.xml EX-101.CAL 47786
19 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbse-20190930_def.xml EX-101.DEF 174427
20 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbse-20190930_lab.xml EX-101.LAB 509135
21 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbse-20190930_pre.xml EX-101.PRE 386759
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-35963 | Film No.: 20521183
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences